Calendar

Events that a source expects, grouped by the month, quarter or half-year the source names, with who expected each and when they said so.

Upcoming as of , the date this release was built (the newest input commit date), not today's date. An expected date is a statement by the source, not a result, and it can move. Dated events are on the timeline.

8,817 of these dates come from registry records: the start, primary completion or completion that a registry expects of a trial. A program assembled them, and a registry often leaves a date unchanged after it has passed. The calendar file lists the dates of written pages only.

Add to your calendar (calendar.ics)

The calendar file has one all-day event for each upcoming item. Where a source gives only a month, a quarter, a half-year or a year, the event sits on the first day of that period and its title says "expected sometime in" the period.

Upcoming

August 2030 13

  1. Study completion CATCH AF - Atrial Fibrillation Detection in Cryptogenic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07899788

September 2030 32

  1. Study completion Short-Term Anticoagulation Versus Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03568890

  2. Study completion Short-term Cervical Spinal Cord Stimulation in Patients With Disorders of Consciousness After Intracerebral Hemorrhage Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05922644

  3. Primary completion GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissections Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06827990

  4. Primary completion Pre-emptive Coil Embolization in Endovascular Aortic Repair Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06975215

  5. Primary completion Semaglutide in Patients Undergoing Transcatether Aortic Valve Replacement Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07090343

  6. Primary completion Postpartum Semaglutide to Reduce Cardiometabolic Risk After Gestational Diabetes Mellitus Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07797036

  7. Study completion Heart Rate Regularization in Atrial Fibrilation and Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05029570

  8. Study completion Intravenous Fish Oil Based Lipid Emulsion to Enhance Recovery in High-Risk Cardiac Surgery Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06279793

  9. Primary completion The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06494878

  10. Study completion Pivotal Study of the Velocity™ pAVF System Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07153939

  11. Study completion FIM+DASH: Food is Medicine Intervention to Promote Healthy Eating and Blood Pressure Control Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07332741

  12. Study completion A Study Of Stellate Ganglion Blockade With Liposomal Bupivacaine In Preventing Atrial Fibrillation After Isolated Coronary Artery Bypass Grafting Surgery Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07570940

  13. Primary completion A Study Of Stellate Ganglion Blockade With Liposomal Bupivacaine In Preventing Atrial Fibrillation After Isolated Coronary Artery Bypass Grafting Surgery Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07570940

  14. Study completion Alirocumab for Stabilisation of Symptomatic Vulnerable Carotid Plaque Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07586540

  15. Study completion A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07794579

  16. Study completion Very-Low-Field MRI for the Diagnosis of Acute Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07930013

  17. Study completion SEAL™IT: Saccular Endovascular Aneurysm Lattice System Interventional Pivotal Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05831202

  18. Study completion ULTRAsound-assisted Catheter-guided Thrombolysis for Intermediate-high Risk Patients With PE Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07452991

  19. Study completion ElectroPhySiological Characterization Of the Arrhythmia Substrate for Sudden Cardiac Death PrEdiction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07020702

  20. Primary completion ElectroPhySiological Characterization Of the Arrhythmia Substrate for Sudden Cardiac Death PrEdiction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07020702

  21. Study completion Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07181109

  22. Primary completion Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07181109

  23. Study completion Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07037433

  24. Study completion Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07037459

  25. Primary completion ACT-GLOBAL THROMBOLYSIS (ACT-WHEN-001) Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632 Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06320431

  26. Study completion Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07001800

  27. Primary completion PRECISION-CPR: PRecision-Controlled Ventilation in CPR Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07088120

  28. Study completion Corheart 6: Long-term Cohort Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07094919

  29. Study completion A Randomized Trial of Six-Channel RF Ablation System for Renal Denervation in Uncontrolled Hypertension and Chronic Kidney Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07130955

  30. Study completion PATHS-T2D: A Recall-by-Genotype Study of Physiologic and Pharmacologic Responses Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07739537

  31. Study completion Achieving Optimal Medical Therapy Through Percutaneous Treatment of Secondary Mitral Regurgitation to Improve Outcome in Patients With HFrEF Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07758023

  32. Primary completion Achieving Optimal Medical Therapy Through Percutaneous Treatment of Secondary Mitral Regurgitation to Improve Outcome in Patients With HFrEF Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07758023

October 2030 22

  1. Study completion Left Atrial Appendage Occlusion Versus Novel Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03642509

  2. Study completion Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI-DTU Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03947619

  3. Study completion Encore PFO Closure Device - The PerFOrm Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05537753

  4. Study completion Postoperative Intravenous Ferric Derisomaltose for Prevention of Long-term Anemia After Cardiac Surgery Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07238972

  5. Study completion A Phase 3 Trial of DR10624 Versus Placebo in Patients With Severe Hypertriglyceridemia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07680829

  6. Study completion Smartphone Application to PREDICT Real-Time Cardiovascular Risk for Heart Attack and Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07735338

  7. Primary completion Smartphone Application to PREDICT Real-Time Cardiovascular Risk for Heart Attack and Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07735338

  8. Primary completion Routine Microaxial Heart Pump Support and Protocolized Pulmonary Artery Catheter Monitoring Versus Standard Care in Heart Attack-Related Cardiogenic Shock Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07762560

  9. Study completion Implementing Improved Blood Pressure Measurement in General Practice: A Multisite Implementation Trial Using Automated Office Blood Pressure (AOBP) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07822022

  10. Study completion Aspirin for the Prevention of Ischemic Complications in Giant Cell Arteritis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07908082

  11. Primary completion Aspirin for the Prevention of Ischemic Complications in Giant Cell Arteritis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07908082

  12. Study completion A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07753993

  13. Primary completion A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07753993

  14. Study completion Carotid Implants for PreveNtion of STrokE ReCurrEnce From Large Vessel Occlusion in Atrial Fibrillation Patients Treated With Oral Anticoagulation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05723926

  15. Study completion A Study to Assess the Effect of Pacibekitug on Major Cardiovascular Events in Patients After a Myocardial Infarction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07938411

  16. Primary completion A Study to Assess the Effect of Pacibekitug on Major Cardiovascular Events in Patients After a Myocardial Infarction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07938411

  17. Primary completion Metformin in Acute Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07899307

  18. Study completion The SELUTION DeNovo Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04859985

  19. Primary completion De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05213676

  20. Primary completion Gravity Stroke System for Recanalization of Large Vessel Occlusion Strokes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07335185

November 2030 6

  1. Study completion Study Evaluating the Metabolic Effects of pulsENDO Therapy in Adults With Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07768631

  2. Study completion Cardiac Magnetic Resonance and Echocardiography Study With Acoramidis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07695701

  3. Study completion New Heart Imaging Techniques to Evaluate Possible Heart Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01399385

  4. Study completion Niaoduqing Granules in Older Adults With Impaired Kidney Function Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07741292

  5. Primary completion Niaoduqing Granules in Older Adults With Impaired Kidney Function Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07741292

  6. Primary completion Testing Heart Failure Resilience Intervention for Caregivers (HEROIC) in Advanced Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07805811

December 2030 94

  1. Study completion AMEND-CRT: Mechanical Dyssynchrony as Selection Criterion for CRT Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04225520

  2. Study completion Physician Optimised Post-partum Hypertension Treatment Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04273854

  3. Study completion SELUTION4SFA Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05132361

  4. Study completion Role of GLP1 RA Dulaglutide on Severe Intracranial Atherosclerosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07282041

  5. Primary completion Role of GLP1 RA Dulaglutide on Severe Intracranial Atherosclerosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07282041

  6. Study completion A Study of Chiglitazar in Patients With Metabolic Dysfunction-associated Steatohepatitis and Type 2 Diabetes Mellitus Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07303803

  7. Primary completion A Study of Chiglitazar in Patients With Metabolic Dysfunction-associated Steatohepatitis and Type 2 Diabetes Mellitus Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07303803

  8. Study completion Endovascular Treatment of Thoracic Aortic Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT00583817

  9. Primary completion Endovascular Treatment of Thoracic Aortic Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT00583817

  10. Study completion Post Stroke Motor Learning Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01519843

  11. Study completion Improving Bi-manual Activities in Stroke Patients With Application of Neuro-stimulation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02308852

  12. Primary completion Implantable Cardioverter Defibrillator Versus Optimal Medical Therapy In Patients With Variant Angina Manifesting as Aborted Sudden Cardiac Death Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02845531

  13. Study completion Medtronic Transcatheter Aortic Valve Replacement (TAVR) Low Risk Bicuspid Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03635424

  14. Study completion The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves). Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04408430

  15. Study completion Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05347069

  16. Study completion Preventive Drug-coated Balloon Angioplasty in Vulnerable Atherosclerotic Plaque (RESTORE Trial) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06365502

  17. Study completion The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06494878

  18. Primary completion International Study of Comparative Health Effectiveness With Medical and Invasive Approaches-Left Ventricular Dysfunction Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06566183

  19. Study completion LEADERS FREE IV (RCT): BioFreedom™ Ultra vs BioFreedom™ in HBR Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06657326

  20. Study completion Application of TAVI at Experienced Interventional Cardiac Centers Without On-site Cardiac Surgery (ATLAS Study) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06818006

  21. Primary completion Application of TAVI at Experienced Interventional Cardiac Centers Without On-site Cardiac Surgery (ATLAS Study) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06818006

  22. Study completion Finerenone and Cardiac Remodeling Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07270367

  23. Primary completion Finerenone and Cardiac Remodeling Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07270367

  24. Study completion Neuromodulation for Metabolic Dysfunction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07597161

  25. Study completion DCB Outcomes After Non-Compliant Balloon Vessel Preparation With or Without Scoring in Patients With Femoropopliteal Arterial Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07764016

  26. Study completion Negative Pressure Wound Therapy Devices in Total Knee Arthroplasty Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07770633

  27. Primary completion The NICE-PAD II Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07782671

  28. Study completion OPTImizing Lead Placement in Patients Requiring Pacemaker After Cardiac Surgery Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07795541

  29. Primary completion OPTImizing Lead Placement in Patients Requiring Pacemaker After Cardiac Surgery Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07795541

  30. Primary completion Ticagrelor for Inflammation and Cardiovascular Risk in Patients With Chronic Kidney Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07911124

  31. Primary completion Post Market Clinical Follow-Up Registry Study of the aXess Hemodialysis Conduit Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07925502

  32. Study completion A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04557462

  33. Primary completion A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04557462

  34. Study completion Pelacarsen Roll-over Extension Program Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06875973

  35. Primary completion Pelacarsen Roll-over Extension Program Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06875973

  36. Study completion Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04684602

Overdue

The expected date has passed and no published record says the event happened. This does not mean it failed or was delayed: the atlas may not have checked the source since. Oldest first.

  1. Study completion Pair Antiplatelet THerapy in Ischemic Stroke With Intracranial Artery Stenosis Registry record

    Expected 2026-03-31; that period ended on 2026-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06243133

  2. Primary completion Pair Antiplatelet THerapy in Ischemic Stroke With Intracranial Artery Stenosis Registry record

    Expected 2026-03-31; that period ended on 2026-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06243133

  3. Study completion FibriCheck Data Registry Registry record

    Expected 2026-03; that period ended on 2026-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06282393

  4. Study completion Efficacy and Safety of DA5221-T When Added to Ongoing DA5221-B1 and DA5221-B2 Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control Registry record

    Expected 2026-03-31; that period ended on 2026-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06290349

  5. Primary completion Amplitude Vascular Systems (AVS) Lithotripsy POWER PAD 2 Trial Registry record

    Expected 2026-03; that period ended on 2026-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06457685

  6. Study completion Colchicine in Patients With Heart Failure With Preserved Ejection Fraction and Inflammation Registry record

    Expected 2026-03-31; that period ended on 2026-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06604611

  7. Primary completion Phase 3 Trial to Evaluate the Efficacy and Safety of CKD-202A Registry record

    Expected 2026-03-31; that period ended on 2026-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06643819

  8. Study completion The Effects of Xuezhikang and Atorvastatin on Lipid in Patients With Dyslipidemia and Prediabetes Registry record

    Expected 2026-03-31; that period ended on 2026-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06750783

  9. Primary completion The Effects of Xuezhikang and Atorvastatin on Lipid in Patients With Dyslipidemia and Prediabetes Registry record

    Expected 2026-03-31; that period ended on 2026-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06750783

  10. Study completion Study on the Sex-specific, Lipid- and Lipoprotein-lowering Effects of Berberine Registry record

    Expected 2026-03; that period ended on 2026-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06782646

  11. Study start National Trial of CGM in Pregnant Women With Type 2 Diabetes Registry record

    Expected 2026-03; that period ended on 2026-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06903728

  12. Study start Evaluate the Efficacy and Safety of Empagliflozin or Glimepiride Combination Therapy in Type 2 Diabetes Mellitus Patients Registry record

    Expected 2026-03; that period ended on 2026-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07365358

  13. Study start A Study to Evaluate the Safety, Efficacy of SYH2053 in Chinese Participants With Non-familial Hypercholesterolemia and Mixed Hyperlipidemia on a Background of Lipid-lowering Therapy Registry record

    Expected 2026-03-31; that period ended on 2026-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07421284

  14. Study start QLC7401 in the Treatment of Primary Hypercholesterolemia or Mixed Hyperlipidemia With Elevated Low Density Lipoprotein Cholesterol (LDL-C) Registry record

    Expected 2026-03; that period ended on 2026-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07441317

  15. Study start DECODE - Haemodynamic Effects Of Semaglutide and Tirzepatide - a Series of Pilot Studies Registry record

    Expected 2026-03; that period ended on 2026-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07483801

  16. Study completion tDCS and rTMS in Patients With Early Disorders of Consciousness Registry record

    Expected 2026-04-01; that period ended on 2026-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05820178

  17. Primary completion tDCS and rTMS in Patients With Early Disorders of Consciousness Registry record

    Expected 2026-04-01; that period ended on 2026-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05820178

  18. Study start Gathering Evidence on Best Practices for Lay Rescuer CPR Training Registry record

    Expected 2026-04-01; that period ended on 2026-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05908500

  19. Primary completion DragonFly EU Pivotal Study Registry record

    Expected 2026-04-01; that period ended on 2026-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05927441

  20. Study completion Oral Bedtime Melatonin in Critically Ill Patients Registry record

    Expected 2026-04-01; that period ended on 2026-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06156059

  21. Study completion Phitys I™ Percutaneous Left Ventricular Assist System Study Registry record

    Expected 2026-04-01; that period ended on 2026-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06357026

  22. Study start Second Line Endovascular Treatment in Acute DVT Registry record

    Expected 2026-04-01; that period ended on 2026-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06486181

  23. Primary completion Study of Tiprogrel in the Treatment of High-risk Patients with Acute Ischemic Cerebrovascular Events (THRIVE). Registry record

    Expected 2026-04-01; that period ended on 2026-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06601127

  24. Primary completion RCT Glargine vs NPH for Treatment of DM in Pregnancy Registry record

    Expected 2026-04-01; that period ended on 2026-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06619301

  25. Study completion Remote Ischemic Conditioning for Efficacy in Patients With Aneurysmal Subarachnoid Hemorrhage Registry record

    Expected 2026-04-01; that period ended on 2026-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06711302

  26. Study start Semaglutide in Patients Undergoing Transcatether Aortic Valve Replacement Registry record

    Expected 2026-04-01; that period ended on 2026-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07090343

  27. Study start Foundation Model for Post-MI Cardiovascular Event Alert Using Huawei Watch Registry record

    Expected 2026-04-01; that period ended on 2026-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07395648

  28. Study start Evaluation of the HeartLogic Diagnostic in Optimizing Guideline-directed Medical Therapy in Patients With Congestive Heart Failure and Chronically Low Ejection Fractions (EFs) Registry record

    Expected 2026-04-01; that period ended on 2026-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07412626

  29. Study start Perioperative Lidocaine for Lung Protection in Infants Undergoing Cardiac Surgery Registry record

    Expected 2026-04-01; that period ended on 2026-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07499154

  30. Study start Digital Application for Stroke Health Registry record

    Expected 2026-04-01; that period ended on 2026-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07511868

  31. Study start AERO CAD Study Evaluating the Shockwave C2 Aero IVL System in Coronary Artery Disease Registry record

    Expected 2026-04-01; that period ended on 2026-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07512206

  32. Study start Butylphthalide for Brain Edema After Endovascular Treatment Registry record

    Expected 2026-04-01; that period ended on 2026-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07528456

  33. Study completion Optical Coherence Tomography of the Saphenous Vein Graft Registry record

    Expected 2026-04-04; that period ended on 2026-04-04.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05129228

  34. Primary completion Carotid Artery Stenting During Endovascular Treatment of Acute Stroke Registry record

    Expected 2026-04-05; that period ended on 2026-04-05.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06511089

  35. Study start Evaluate the Efficacy and Safety of GZR101-80 Injection in Patients With Type 2 Diabetes Registry record

    Expected 2026-04-10; that period ended on 2026-04-10.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07387003

  36. Study start Head Cooling in Ischaemic Stroke Patients Undergoing Endovascular Thrombectomy (COOLHEAD-2b) Registry record

    Expected 2026-04-10; that period ended on 2026-04-10.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07526649

  37. Study start Intravascular Ultrasound- and Angiography-Derived Fractional Flow Reserve-Guided Drug-Coated Balloon for Large Coronary Artery De Novo Lesions Registry record

    Expected 2026-04-10; that period ended on 2026-04-10.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07548281

  38. Study completion DENEX Renal Denervation in Patients With Hypertension on no Antihypertensive Medications Registry record

    Expected 2026-04-15; that period ended on 2026-04-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04535050

  39. Primary completion Trial to Assess the Safety and Efficacy of Sirolimus-Coated Balloon vs. Uncoated Standard Angioplasty for the Treatment of Below-the-knee Peripheral Arterial Disease Registry record

    Expected 2026-04-17; that period ended on 2026-04-17.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04772300

  40. Study start Argus 2.0 Adoption Study Registry record

    Expected 2026-04-19; that period ended on 2026-04-19.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07425236

  41. Study start Study of the Long-term Effects of P2Y12 Inhibitor Monotherapy and Coagulation Markers After Percutaneous Coronary Angioplasty. Registry record

    Expected 2026-04-20; that period ended on 2026-04-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07582835

  42. Study completion Mitral Regurgitation Treatment in Advanced Heart Failure Registry record

    Expected 2026-04-21; that period ended on 2026-04-21.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05292716

  43. Study completion Structural Heart Surgery Assist System for Transcatheter Mitral Valve Edge-to-Edge Repair (TEER). Registry record

    Expected 2026-04-22; that period ended on 2026-04-22.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07055919

  44. Study start Ongericimab Injection Reducing Recurrence of Ischemic Stroke Registry record

    Expected 2026-04-22; that period ended on 2026-04-22.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07242599

  45. Study start Echo-Guided vs Fluoroscopy-Guided Transcatheter Aortic Valve Replacement in Patients With Aortic Stenosis(ECHO-TAVR) Registry record

    Expected 2026-04-26; that period ended on 2026-04-26.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07317804

  46. Study completion Chronic Venous Thrombosis: Relief With Adjunctive Catheter-Directed Therapy (The C-TRACT Trial) Registry record

    Expected 2026-04-27; that period ended on 2026-04-27.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03250247

  47. Study completion Continuous Glucose Monitoring Devices in Hospitalized Veterans With Diabetes Registry record

    Expected 2026-04-30; that period ended on 2026-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03508934

  48. Study completion MAGNAM Trial, Magnesium Versus Amiodarone in Atrial Fibrillation in Critical Care Registry record

    Expected 2026-04-30; that period ended on 2026-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05287191

  49. Primary completion Encore PFO Closure Device - The PerFOrm Trial Registry record

    Expected 2026-04; that period ended on 2026-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05537753

  50. Study completion Transfemoral Transcatheter Aortic Valve Implementation at Hospital Without On-site Cardiac Surgery: Early Clinical Outcome in Patients With Prohibitive Surgical Risk. Registry record

    Expected 2026-04; that period ended on 2026-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05886517

  51. Primary completion The Effect of phoSPHocreatine on mEdical Emergency Team (Met) tREated Patients Registry record

    Expected 2026-04; that period ended on 2026-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06503016

  52. Study completion Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients With Hypertension and Dyslipidemia Registry record

    Expected 2026-04; that period ended on 2026-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06643130

  53. Primary completion Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients With Hypertension and Dyslipidemia Registry record

    Expected 2026-04; that period ended on 2026-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06643130

  54. Primary completion QR12000 Compound Tablets in Patients with Moderate to Severe Essential Hypertension Registry record

    Expected 2026-04-30; that period ended on 2026-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06716970

  55. Study completion The Investigator Administers Intracoronary Adrenaline Via the Catheter in STEMI Patients During Primary PCI, After Flow Restoration and Before Stenting, and Studies Its Effect in Prevention of No Reflow Registry record

    Expected 2026-04-30; that period ended on 2026-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06847568

  56. Primary completion The Investigator Administers Intracoronary Adrenaline Via the Catheter in STEMI Patients During Primary PCI, After Flow Restoration and Before Stenting, and Studies Its Effect in Prevention of No Reflow Registry record

    Expected 2026-04-30; that period ended on 2026-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06847568

  57. Primary completion Intranasal Dexmedetomidine on Blood Pressure in Elderly Hypertensive Patients Undergoing Cataract Surgery Registry record

    Expected 2026-04; that period ended on 2026-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07080229

  58. Study completion The Study of Efficacy and Safety of Dimephosphon® in Acute Ischemic Stroke Registry record

    Expected 2026-04-30; that period ended on 2026-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07167550

  59. Primary completion RK-4 Intracalvariosseous Injection in Treatment of Acute Large Hemispheric Infarction Registry record

    Expected 2026-04-30; that period ended on 2026-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07203521

  60. Study start STAR Trial (Siegel Transcatheter Aortic Valve Replacement in Patients With Symptomatic Severe Aortic Stenosis) Registry record

    Expected 2026-04; that period ended on 2026-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07278310

  61. Study start A Study Comparing the MAGICTouch™ Sirolimus-coated Balloon With a Paclitaxel-coated Balloon for Treating Severe Narrowing or Blockage in the Femoropopliteal Arteries. Registry record

    Expected 2026-04; that period ended on 2026-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07359807

  62. Primary completion Atrial Fibrillation TRIal of Left Atrial Appendage Closure Using Seralene Hemostatic Suture Registry record

    Expected 2026-04-30; that period ended on 2026-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07360899

  63. Study start COMPETE-LM Trial: Drug-Coated Balloon-Enhanced Provisional Stenting in Complex Left Main Disease. Registry record

    Expected 2026-04; that period ended on 2026-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07408674

  64. Study start QLS1410 in Participants With Uncontrolled Hypertension Registry record

    Expected 2026-04; that period ended on 2026-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07489612

  65. Study start AI-based Customized tDCS for Finger Motor Recovery After Subacute Stroke Registry record

    Expected 2026-04-30; that period ended on 2026-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07491029

  66. Study start Normal Saline Infusion After Intravenous Thrombolysis in Stroke Registry record

    Expected 2026-04; that period ended on 2026-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07497542

  67. Study start WEARABLE-BP: Wearable Everyday Automated Readings to Enable Assessment of Blood Pressure Control Registry record

    Expected 2026-04; that period ended on 2026-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07523269

  68. Study start Self-Expanding Hydra Transcatheter Heart Valve (THV) Series Versus Balloon-Expandable Devices for Valve-In-Valve Transcatheter Aortic Valve Implantation (TAVI) for Patients With Failed Surgical Aortic Bioprosthesis. Registry record

    Expected 2026-04; that period ended on 2026-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07524595

  69. Study start Safety and Efficacy of the AbsnowTM II Absorbable Atrial Septal Defect Closure System for Atrial Septal Defect Closure Therapy Registry record

    Expected 2026-04; that period ended on 2026-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07529028

  70. Study start Intra-Arterial Tirofiban After Complete Recanalization for Acute Intracranial Large-Vessel Occlusion Registry record

    Expected 2026-04; that period ended on 2026-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07537933

  71. Study start AI-assisted Multi-domain Lifestyle Versus Tirzepatide for Weight Loss Maintenance in Adults With Type 2 Diabetes (AIM-MAINTAIN) Registry record

    Expected 2026-04-30; that period ended on 2026-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07555730

  72. Study start Covered vs Bare Metal Stents for Atherosclerotic Renal Artery Stenosis Registry record

    Expected 2026-04-30; that period ended on 2026-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07566065

  73. Primary completion Left Atrial Appendage Occlusion for AF Patients Unable to Use Oral Anticoagulation Therapy Registry record

    Expected 2026-05-01; that period ended on 2026-05-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04676880

  74. Primary completion Effects of Individualized iTBS on Upper Limb Function After Stroke Registry record

    Expected 2026-05-01; that period ended on 2026-05-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06147167

  75. Primary completion A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Placebo in T2DM Patients Registry record

    Expected 2026-05-01; that period ended on 2026-05-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06254014

  76. Study completion Ticagrelore Alone Post PCI Registry record

    Expected 2026-05-01; that period ended on 2026-05-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06509893

  77. Study completion Ali Pay Intelligent Navigation Applet-aided Pre-hospital Triage for Non-emergency Medical Service Patients With Acute Ischemic Stroke Registry record

    Expected 2026-05-01; that period ended on 2026-05-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06613074

  78. Primary completion Ali Pay Intelligent Navigation Applet-aided Pre-hospital Triage for Non-emergency Medical Service Patients With Acute Ischemic Stroke Registry record

    Expected 2026-05-01; that period ended on 2026-05-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06613074

  79. Primary completion Wide-Antral Pulmonary Vein Isolation in Atrial Fibrillation Ablation with a Single-shot Technique (WIDER-PVI) Registry record

    Expected 2026-05-01; that period ended on 2026-05-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06698159

  80. Study start Trial of Mobile External Defibrillator for Out-of-hospital Cardiac Arrest in Singapore. Registry record

    Expected 2026-05-01; that period ended on 2026-05-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07042061

  81. Primary completion Bioimpedance Integration for Optimized Fluid Management in Decompensated Heart Failure Registry record

    Expected 2026-05-01; that period ended on 2026-05-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07173426

  82. Study start Mandibular Advancement to Reduce Ventricular Load and Improve Quality-of-life in Heart Failure Registry record

    Expected 2026-05-01; that period ended on 2026-05-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07460505

  83. Study start Efficacy and Safety of QLG1091 vs Rybelsus as add-on to Metformin in Subjects With Type 2 Diabetes Registry record

    Expected 2026-05-01; that period ended on 2026-05-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07487103

  84. Study start Triple vs Dual Lipid-Lowering Therapy for LDL-C Reduction in Acute Coronary Syndrome Registry record

    Expected 2026-05-01; that period ended on 2026-05-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07508254

  85. Study start Safety and Efficacy of Remote Ischemic Conditioning in Patients With Acute Myocardial Injury Following Acute Ischemic Stroke Registry record

    Expected 2026-05-01; that period ended on 2026-05-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07531394

  86. Study start Early Low-dose ASpirin Use After Intravenous Thrombolysis for Acute Ischemic Cerebral Infarction(ELASTIC) Registry record

    Expected 2026-05-01; that period ended on 2026-05-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07563673

  87. Study completion Individualized Precision rTMS for Language Recovery in Patients After Ischemic Stroke: a Multi-center RCT Registry record

    Expected 2026-05-10; that period ended on 2026-05-10.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05842304

  88. Primary completion Concomitant Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Small Vessel Stroke Registry record

    Expected 2026-05-10; that period ended on 2026-05-10.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06358313

  89. Study start Efficacy of Remote Ischemic Conditioning for Hypertension in High-Altitude Immigrant Populations Registry record

    Expected 2026-05-10; that period ended on 2026-05-10.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07562477

  90. Study completion A Phase 3 Study of Zalunfiban in Subjects With ST-elevation MI Registry record

    Expected 2026-05-13; that period ended on 2026-05-13.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04825743

  91. Primary completion A Phase 3 Study of Zalunfiban in Subjects With ST-elevation MI Registry record

    Expected 2026-05-13; that period ended on 2026-05-13.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04825743

  92. Study start Effect of Finerenone on Myocardial Fibrosis and Cardiac Function in HFmrEF/HFpEF Patients Registry record

    Expected 2026-05-15; that period ended on 2026-05-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07583173

  93. Study start Clinical, Organizational, and Care Impact of the GetReady Digital Platform as a Clinical Decision Support Tool in the Follow-up of Patients With Cerebral Aneurysm Registry record

    Expected 2026-05-18; that period ended on 2026-05-18.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07569562

  94. Study start Recombinant Human Thymosin Beta 4 for Injection(NL005) for Acute Myocardial Infarction Registry record

    Expected 2026-05-18; that period ended on 2026-05-18.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07586865

  95. Study start Low-VOLTage Area-Guided Catheter Ablation and SVC Isolation for Persistent Atrial Fibrillation Using a Balloon-in-Basket Pulsed Field Ablation Catheter Registry record

    Expected 2026-05-18; that period ended on 2026-05-18.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07587541

  96. Study completion Efficacy and Safety of Edoxaban in Patients With Atrial Fibrillation and Mitral Stenosis Registry record

    Expected 2026-05-20; that period ended on 2026-05-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05540587

  97. Study completion Phase-III Clinical Studies on Poly Herbal Anti-Diabetic Formulation Registry record

    Expected 2026-05-20; that period ended on 2026-05-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07279909

  98. Study start Reperfusion Approach in Predicted In-hospital Delay for Primary PCI in STEMI Registry record

    Expected 2026-05-20; that period ended on 2026-05-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07641231

  99. Study start A Study of the Effect and Safety of HS-10390 in the Treatment of Participants With Chronic Kidney Disease Registry record

    Expected 2026-05-21; that period ended on 2026-05-21.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07555054